This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Buoyed by outside funding, US patent trials — and damages — soar in 2024

By Melissa Ritti ( June 16, 2025, 15:49 GMT | Comment) -- A new report from Lex Machina shows patent litigation remains highly lucrative and concentrated in a handful of US district courts. While the three judges overseeing the bulk of the nation’s patent cases remain unchanged, their courtrooms generated less in damages in 2023 and 2024 than in the two years prior. In good news for patentees, however, trials before other federal judges more than made up the gap. Whether 2025 can top the "record breaking" awards seen in 2024 will largely hinge on how district courts interpret new precedent by an en banc US Court of Appeals for the Federal Circuit.Sizable damages remain available to patent owners willing, and able, to take their rivals to trial in the US....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections